Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.20.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2020
Jun. 30, 2019
Accounts payable, related parties $ 19 $ 125
Accrued expenses, related parties $ 840 $ 699
Preferred Stock, Shares Authorized 1,000,000  
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 275,000,000 275,000,000
Common Stock, Shares, Issued 107,360,032 20,152,458
Common Stock, Shares, Outstanding 107,360,032 20,152,458
iBio CMO [Member]    
Preferred Stock, No Par Value $ 0 $ 0
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Preferred Stock, Shares Issued 1 1
Preferred Stock, Shares Outstanding 1 1
Series A Preferred Stock [Member]    
Preferred Stock, No Par Value $ 1,000 $ 1,000
Preferred Stock, Shares Authorized 6,300 6,300
Preferred Stock, Shares Issued 0 3,987
Preferred Stock, Shares Outstanding 0 3,987
Series B Preferred Stock [Member]    
Preferred Stock, No Par Value $ 1,000 $ 1,000
Preferred Stock, Shares Authorized 5,785 5,785
Preferred Stock, Shares Issued 5,785 5,785
Preferred Stock, Shares Outstanding 5,785 5,785
Series C Preferred Stock [Member]    
Preferred Stock, No Par Value $ 1,000 $ 1,000
Preferred Stock, Shares Authorized 4,510 4,510
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0